关注
Vijay Ramakrishnan
Vijay Ramakrishnan
Associate Director Oncology Biomarkers, Biomarker Solution Center, LabCorp
在 covance.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Bortezomib combination therapy in multiple myeloma
P Kapoor, V Ramakrishnan, SV Rajkumar
Seminars in hematology 49 (3), 228-242, 2012
1112012
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
V Ramakrishnan, M Timm, JL Haug, TK Kimlinger, LE Wellik, TE Witzig, ...
Oncogene 29 (8), 1190-1202, 2010
1102010
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells
V Ramakrishnan, T Kimlinger, J Haug, M Timm, L Wellik, T Halling, ...
American journal of hematology 85 (9), 675-686, 2010
802010
PI3K/AKT/mTOR pathway in multiple myeloma: from basic biology to clinical promise
V Ramakrishnan, S Kumar
Leukemia & lymphoma 59 (11), 2524-2534, 2018
782018
MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma
V Ramakrishnan, S Ansell, J Haug, D Grote, T Kimlinger, M Stenson, ...
Leukemia 26 (2), 340-348, 2012
762012
Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathway
V Ramakrishnan, T Kimlinger, J Haug, U Painuly, L Wellik, T Halling, ...
PloS one 7 (11), e50005, 2012
742012
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
N Tandon, V Ramakrishnan, SK Kumar
Clinical pharmacology: advances and applications, 35-44, 2016
682016
Amblyomma americanum salivary glands: double-stranded RNA-mediated gene silencing of synaptobrevin homologue and inhibition of PGE2 stimulated protein secretion
S Karim, VG Ramakrishnan, JS Tucker, RC Essenberg, JR Sauer
Insect biochemistry and molecular biology 34 (4), 407-413, 2004
592004
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma
V Ramakrishnan, U Painuly, T Kimlinger, J Haug, SV Rajkumar, S Kumar
Leukemia 28 (7), 1519-1528, 2014
582014
Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies
WI Gonsalves, V Ramakrishnan, T Hitosugi, T Ghosh, D Jevremovic, ...
JCI insight 3 (1), 2018
492018
Sorafenib, a multikinase inhibitor, is effective in vitro against non‐hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin
V Ramakrishnan, M Timm, JL Haug, TK Kimlinger, T Halling, LE Wellik, ...
American journal of hematology 87 (3), 277-283, 2012
392012
Microarray analysis of gene expression changes in feeding female and male lone star ticks, Amblyomma americanum (L)
MN Aljamali, VG Ramakrishnan, H Weng, JS Tucker, JR Sauer, ...
Archives of Insect Biochemistry and Physiology: Published in Collaboration …, 2009
392009
Amblyomma americanum salivary gland homolog of nSec1 is essential for saliva protein secretion
S Karim, VG Ramakrishnan, JS Tucker, RC Essenberg, JR Sauer
Biochemical and biophysical research communications 324 (4), 1256-1263, 2004
332004
Signaling pathways and emerging therapies in multiple myeloma
V Ramakrishnan, A D’Souza
Current hematologic malignancy reports 11, 156-164, 2016
322016
Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma
VG Ramakrishnan, KC Miller, EP Macon, TK Kimlinger, J Haug, S Kumar, ...
Haematologica 104 (10), 2061, 2019
292019
Application of RNA interference in tick salivary gland research
VG Ramakrishnan, MN Aljamali, JR Sauer, RC Essenberg
Journal of Biomolecular Techniques: JBT 16 (4), 297, 2005
292005
Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma
V Ramakrishnan, M Gomez, V Prasad, T Kimlinger, U Painuly, ...
Oncotarget 7 (35), 56253, 2016
282016
Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001
V Ramakrishnan, T Kimlinger, M Timm, J Haug, SV Rajkumar, S Kumar
Leukemia research 38 (11), 1358-1366, 2014
162014
In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma
AK Mitra, H Kumar, V Ramakrishnan, L Chen, L Baughn, S Kumar, ...
Blood cancer journal 10 (7), 78, 2020
132020
Natriuretic peptides, inflammation, and sounding the alarm
V Ramakrishnan, JC Burnett Jr
Circulation: Heart Failure 13 (7), e007208, 2020
82020
系统目前无法执行此操作,请稍后再试。
文章 1–20